Kymera Therapeutics
KYMR
$37.40
Share price
3.03%
Change (1 day)
21.04%
Change (1 year)
Categories
Kymera Therapeutics (KYMR) - Cash on Hand
Cash on Hand as of December 2023 : $0.37 B
According to Kymera Therapeutics's latest financial reports the company has $0.37 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Kymera Therapeutics - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.37 B | -7.93% |
| 2022-12-31 | $0.40 B | -7.97% |
| 2021-12-31 | $0.44 B | 49.36% |
| 2020-12-31 | $0.29 B | 222.11% |
| 2019-12-31 | $91.95 M | 122.87% |
| 2018-12-31 | $41.26 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -44.47% | 🇺🇸 USA |